Peak Financial Advisors LLC purchased a new position in Lam Research Corporation (NASDAQ:LRCX – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 3,996 shares of the semiconductor company’s stock, valued at approximately $684,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in LRCX. PMV Capital Advisers LLC bought a new stake in shares of Lam Research during the fourth quarter valued at approximately $25,000. Stance Capital LLC bought a new position in shares of Lam Research during the third quarter worth $26,000. Howard Hughes Medical Institute purchased a new position in Lam Research during the second quarter valued at $27,000. Triumph Capital Management bought a new stake in Lam Research in the 3rd quarter valued at $27,000. Finally, Strategic Wealth Investment Group LLC bought a new stake in Lam Research in the 2nd quarter valued at $29,000. 84.61% of the stock is currently owned by institutional investors.
Lam Research Stock Down 2.3%
Shares of NASDAQ:LRCX opened at $233.45 on Thursday. The company has a market cap of $291.53 billion, a price-to-earnings ratio of 47.84, a PEG ratio of 2.57 and a beta of 1.77. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $256.68. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. The company has a 50-day moving average price of $228.16 and a 200 day moving average price of $180.40.
Lam Research Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.4%. The ex-dividend date is Wednesday, March 4th. Lam Research’s dividend payout ratio is presently 21.31%.
Insider Activity at Lam Research
In related news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the sale, the director directly owned 253,705 shares in the company, valued at $57,235,848. This trade represents a 12.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ava Harter sold 1,500 shares of the business’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $222.66, for a total transaction of $333,990.00. Following the transaction, the insider owned 53,205 shares in the company, valued at $11,846,625.30. This trade represents a 2.74% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 130,886 shares of company stock worth $29,658,802. Company insiders own 0.31% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have commented on LRCX shares. Evercore set a $275.00 price objective on shares of Lam Research in a report on Thursday, January 29th. Barclays lifted their target price on Lam Research from $250.00 to $255.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 10th. New Street Research increased their price target on Lam Research from $195.00 to $235.00 and gave the company a “neutral” rating in a research note on Friday, January 30th. Summit Insights upgraded Lam Research from a “hold” rating to a “buy” rating in a report on Thursday, January 29th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $290.00 price objective (up from $260.00) on shares of Lam Research in a report on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $245.35.
Get Our Latest Stock Report on LRCX
Key Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Analysts argue Lam still has strong growth ahead driven by secular demand in advanced node fabs and rising wafer complexity, supporting revenue and margin expansion. Lam Research: Strong Growth Ahead For This Expensive Stock
- Positive Sentiment: Investor letters and research highlight Lam’s positioning to benefit from growing chip complexity (more etch/dep/clean steps per wafer), which supports medium-term demand for Lam’s tools. Lam Research Corporation (LRCX) is Positioned to Benefit from Growing Chip Complexity
- Positive Sentiment: Quant/flow signals and headlines report sizable inflows in models that historically flagged long-term outperformance, a technical/market-flow tailwind that has lifted the shares recently. Outlier Inflows Push Lam Research Shares Higher
- Positive Sentiment: Prominent media/TV endorsements (Jim Cramer highlighted Lam as a winner) can reinforce retail and momentum buying. Jim Cramer on Lam Research: “You’ve Got a Winner in Lam Research”
- Positive Sentiment: Several market reports noted Lam outperformed on a day when the broader market dipped, underscoring relative strength vs. peers. Why the Market Dipped But Lam Research (LRCX) Gained Today
- Neutral Sentiment: Quarterly and industry comparisons are being rehashed after Q4 earnings; Lam showed strong top- and bottom-line beats but investor focus is now on sustainability of cycle and capex cadence. A Look Back at Semiconductor Manufacturing Stocks’ Q4 Earnings: Lam Research (NASDAQ:LRCX) Vs The Rest Of The Pack
- Neutral Sentiment: Reports of a “large increase in short interest” contain inconsistent/zero values and appear to be noisy data rather than a clear bearish signal; not currently actionable.
- Negative Sentiment: Valuation scrutiny: multiple pieces note Lam’s premium multiple after a multi‑year run — a high P/E and stretched forward expectations increase sensitivity to any guidance softness or a broader sector rotation, which can trigger pullbacks. Assessing Lam Research (LRCX) Valuation After Strong Multi Year Shareholder Returns
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
